Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 166 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

 		Sickle Cell Disease Phase1, Phase2 United States NCT06546670

A Post Marketing Surveillance on Piqray in Korea

 		Breast Cancer South Korea NCT05293470

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

 		IC-MPGN Phase3 Argentina
Brazil
Canada
France
Germany
Greece
India
Israel
Italy
Japan
Netherlands
Poland
Slovakia
South Korea
Spain
Switzerland
Taiwan
Turkey (Türkiye)
United Kingdom
United States
Vietnam
View all
 NCT05755386

The Belgian REAL (BE.REAL) Registry

 		Atherosclerotic Cardiovascular Disease Belgium NCT05726838

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

 		Atypical Hemolytic Uremic Syndrome Phase3 China
France
Germany
Italy
Japan
Spain
Turkey (Türkiye)
United Kingdom
View all
 NCT05935215

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

 		Lymphatic Malformations Phase2, Phase3 Australia
Belgium
France
Germany
Italy
Netherlands
Spain
United States
View all
 NCT05948943

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

 		Myeloid Leukemia, Philadelphia Positive Phase1, Phase2 China
France
Germany
Greece
Hungary
Italy
Japan
Netherlands
Poland
Russia
South Korea
Thailand
Turkey (Türkiye)
United States
View all
 NCT04925479

Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

 		Relapsing Multiple Sclerosis Portugal NCT05809986

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

 		Hidradenitis Suppurativa Russia NCT06517732

A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma

 		Spinal Muscular Atrophies Brazil NCT06019637